论文部分内容阅读
目的提高残胃癌诊治水平。方法对32例经手术治疗的残胃癌临床资料进行回顾分析。结果确诊残胃癌距首次手术时间平均为26.5年,首次手术BillrothⅡ式25例,占78.1%。残胃癌发生在吻合口占46.9%,残胃小旁侧43.8%,胃底贲门部9.3%,根治切除术后1、3、5年生存率分别为80.2%、42.4%、31.9%。结论胃良性疾病行手术治疗时,应以BillrothⅠ式为首选;定期胃镜检查残胃癌高危人群,早期诊断,早期治疗是提高残胃癌预后的关键。
Objective To improve the diagnosis and treatment of residual gastric cancer. Methods The clinical data of 32 gastric residual gastric cancers treated by surgery were retrospectively analyzed. Results The residual gastric cancer was diagnosed with an average of 26.5 years after the first operation, and Billroth Ⅱ was the first operation in 25 cases (78.1%). Residual gastric cancer occurred in 46.9% of the anastomosis, 43.8% of the small residual gastric stomach, 9.3% of gastric cardia, 1, 3, 5 year survival rate after radical resection were 80.2%, 42.4%, 31.9%. Conclusions Gastric benign disease should be treated with Billroth Ⅰ style when it is surgically treated. Regular gastroscopic examination of gastric cancer patients at high risk of gastric cancer, early diagnosis and early treatment is the key to improve the prognosis of gastric cancer.